Accessibility Menu
Extendicare Stock Quote

Extendicare (TSX: EXE)

$16.13
(-1.1%)
-0.18
Price as of November 4, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
CA$16.13
Daily Change
(-1.1%) $0.18
Day's Range
CA$15.98 - CA$16.30
Previous Close
CA$16.13
Open
CA$16.30
Beta
0.62
Volume
182,799
Average Volume
170,491
Market Cap
1.4B
Market Cap / Employee
$16.13M
52wk Range
CA$9.04 - CA$16.39
Revenue
-
Gross Margin
0.12%
Dividend Yield
3.08%
EPS
CA$0.93
CAPs Rating
-
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Extendicare Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
EXE+83.94%+312.86%+32.79%+17,427%
S&P+18.54%+92.9%+14.04%+7,214%

Extendicare Company Info

Extendicare, Inc. is a holding company, which engages in the provision of nursing care, home health care, retirement living, and management and consulting services. It operates through the following business segments: Long-Term Care, Retirement Living, Home Health Care, and Other Services. The Long-Term Care segment represents long-term care centers the company owns and operates in the country. The Retirement Living segment includes acquired retirement communities, and newly constructed and opened communities. The Other Services segment also offers contract services, consulting and group purchasing services to third parties. The company was founded by Harold Livergant and John MacKay on August 7, 1968 and is headquartered in Markham, Canada.

Financial Health

General

Q2 2025YOY Change
Revenue$383.45M10.0%
Gross Profit$46.42M4.2%
Gross Margin12.10%-0.7%
Market Cap$1.19B96.3%
Net Income$31.93M23.3%
EBITDA$39.79M3.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$148.68M8.2%
Accounts Receivable$95.65M17.1%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$267.25M63.3%
Short Term Debt$16.86M-89.6%

Ratios

Q2 2025YOY Change
Return On Assets11.21%3.1%
Return On Invested Capital7.03%3.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$38.36M10.8%
Operating Free Cash Flow$52.25M18.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings12.5011.9114.1014.3539.58%
Price to Book7.427.808.669.4741.53%
Price to Sales0.640.680.750.8061.42%
Price to Tangible Book Value-46.24-88.81312.55197.47-1198.21%
Price to Free Cash Flow TTM15.9716.4632.6032.70-
Enterprise Value to EBITDA29.6929.4735.9233.8148.61%
Free Cash Flow Yield6.3%6.1%3.1%3.1%-
Return on Equity61.1%70.9%71.6%65.1%8.48%
Total Debt$321.74M$292.49M$286.85M$284.12M-12.92%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.